Ferroheme Options
The changeover in direction of senescence method is governed by a stem cell variable Bcl11b, lack of which accelerates mammary ageing with enhanced DMBA-induced tumor formation. We have discovered a drug TPCA-one that could rejuvenate mammary cells and drastically minimize growing old-linked cancer incidence. Our results create a molecular portrait